Previous 10 | Next 10 |
home / stock / lovff / lovff news
Cannara Biotech ( OTCQB:LOVFF ) announced that on August 31, 2022, Derek Stern, a director and principle shareholder owning more than 10% shares, acquired 720,000 shares in the capital of Cannara, representing ~0.08% of the common shares in the capital of the company. Pur...
Acquisition of Common Shares of Cannara Biotech Inc. Canada NewsWire MONTREAL , Sept. 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of prem...
Cannara Biotech Inc. to Host Investor Webcast on August 17th, 2022 Canada NewsWire MONTREAL , Aug. 10, 2022 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade...
Cannara Biotech ( OTCQB:LOVFF ) announces an exclusive brand partnership with 50-time award-winning US-based cannabis breeder, cultivator and hash maker, Exotic Genetix. This agreement will bring one of the most influential cannabis breeders and his brands from the US to C...
Cannara signs an Exclusive Brand Partnership with Exotic Genetix in Canada Canada NewsWire Agreement grants Cannara an exclusive license to use, sell and distribute Exotic Genetix branded products throughout Canada in addition to providing access to direct breede...
Quebec cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF ) posted positive third-quarter results – showing the resilience of the Québec mega-producer amid waning profits for many throughout the sector. The company announced its thi...
Cannara Biotech press release ( OTCQB:LOVFF ): Q3 GAAP EPS of $0.01. Revenue of $10.1M (+41.1% Y/Y). Recorded gross profit before fair value adjustments of $3.7 million, a 42% increase from the previous quarter and an increase of 7% compared to Q3 2021. Increased posit...
Cannara Biotech Inc. Reports Fiscal Third Quarter 2022 Financial Results Canada NewsWire Company recorded a record high of $10.1 million in quarterly revenue and $24.1 million in year-to-date revenue, delivering its fifth consecutive quarter of positive Q3 ...
Cannara Biotech Inc. Closes $50 Million Credit Facility Led by BMO Commercial Banking Canada NewsWire MONTREAL , June 1, 2022 /CNW Telbec/ - Cannara Biotech Inc. (" Cannara " or the " Company ") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertic...
Cannara Biotech Inc. to Present at Canaccord Genuity's 6th Annual Cannabis Conference on May 11th and Retains Bristol Capital for Investor Relations Services Canada NewsWire MONTREAL , May 4, 2022 /CNW/ - Cannara Biotech Inc. (" Cannara " or the "...
News, Short Squeeze, Breakout and More Instantly...
Cannara Biotech Inc Company Name:
LOVFF Stock Symbol:
OTCMKTS Market:
Cannara Biotech Inc. (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB0) announced its fiscal second quarter 2024 financial and operating results for the three a...
Cannara Biotech Reports Q2 2024 Financial Results Canada NewsWire Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4...
--News Direct-- Cannara Biotech Inc CFO Nicholas Sosiak joined Steve Darling from Proactive to provided valuable insights into the company's success in the cannabis industry. Cannara, based in Montreal, Canada, is a licensed producer with two facilities totaling 1.6 million square fee...